Intas Pharmaceuticals Limited Repaglinide Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Repaglinide Export Records India — #4 Exporter, 173 Shipments, $343.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Repaglinide

India Pharmaceutical Trade Intelligence

$6.9M41 Suppliers36 CountriesHS 30049099

ExportsIndia → UNITED STATES60.4%India → FRANCE15.7%

ImportsGERMANY → India$167.2M DENMARK → India$185.9K

#1 Buyer: AUROLOGISTICS LLC

Intas Pharmaceuticals Limited — Repaglinide Exporter #4 | $343.0K Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Repaglinide Exporter Profile

Indian Pharmaceutical Exporter · #4 for Repaglinide · $343.0K export value · DGFT Verified

Intas Pharmaceuticals Limited is the #4 Indian exporter of Repaglinide with $343.0K in export value and 173 verified shipments. Intas Pharmaceuticals Limited holds a 5.0% market share in Repaglinide exports across 6 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Repaglinide Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Repaglinide export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Repaglinide?

Country	Value	Shipments	Share
CROATIA	$199.5K	20	56.2%
NETHERLANDS	$90.4K	57	25.5%
POLAND	$43.8K	16	12.4%
ITALY	$12.8K	82	3.6%
AUSTRIA

Who Are the Top Buyers of Repaglinide from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
NOVATIN LIMITED	CROATIA	$88.8K	6
BROCACEF NL : HUB	NETHERLANDS	$53.6K	33
NOVATIN LIMITED CONSIGNEMENT STOCK	CROATIA	$50.1K	2
TO THE ORDER.,	CROATIA	$37.0K	4
BROCACEF NL HUB BROCACEF HEALTHCAR	NETHERLANDS	$26.2K	10
NOVATIN LTD CONSIGNEMENT STOCK	CROATIA	$23.6K	8
ACCORD HEALTHCARE POLSKA SP ZOO MAGAZYN IMPORTERA UL LUTOMIERSKA	POLAND	$23.6K	3
ACCORD HEALTHCARE ITALIA SRL	ITALY	$11.3K	6
ALLOGA FRANCE	NETHERLANDS	$10.0K	12
ACCORD HEALTHCARE POLSKA SP. Z.O.O.	POLAND	$8.5K	6

Intas Pharmaceuticals Limited supplies Repaglinide to 23 buyers globally. The largest buyer is NOVATIN LIMITED (CROATIA), followed by BROCACEF NL : HUB (NETHERLANDS) and NOVATIN LIMITED CONSIGNEMENT STOCK (CROATIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Repaglinide Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PH.DRU.& MED.: VATINID 2MG TABLETS REPAGLINIDE TABLETS 2MG EACH TABLET CONTAINS: REPAGLINIDE 2MG [9X10T PER PACK]	$50.1K	2
PHARMA DRUG&MED: VATINID 2MG REPAGLINIDE9X10T(NOVA-CZ)EACH UNCOATED TABLET CONTAINS: REPAGLINIDE 2 MG EXCIPIENTS: Q.S.	$50.0K	1
PH.DRU.& MED.: VATINID 1MG TABLETS REPAGLINIDE TABLETS 1MG EACH TABLET CONTAINS: REPAGLINIDE 1MG [9X10T PER PACK]	$28.3K	2
PHARMA.DRUGS & MEDICINE VATINID 1MG REPAGLINIDE 9X10T(NOVA-CZ)EACH UNCOATED TABLET CONTS:REPAGLINIDE 1MG EXCIPIENTS:Q.S.	$20.3K	3
PHARM DRUG&MED:REPAGLINIDE ACCORD 0.5 MGEACH UNCOATED TABLET CONTAINS :REPAGLINIDE PH.EUR............0.5 MG	$19.9K	2
PH.DRU.& MED.: VATINID 2MG TABLETS (REPAGLINIDE TABLETS 2MG EACH TABLET CONT. REPAGLINIDE 2MG) [11697 PACK X9X10T]	$18.7K	1
PH.DRU.& MED.: VATINID 2MG TABLETS (REPAGLINIDE TABLETS 2MG EACH TABLET CONT. REPAGLINIDE 2MG) [11363 PACK X9X10T]	$18.2K	1
PHARM DRUG&MED:REPAGLINIDE 2MG 9X10TACORD-CZEACH UNCOATED TABLET CONTAINS :REPAGLINIDE PH.EUR............2 MG	$17.4K	2
PHARMA DRUGS & MEDI Repaglinide Accord 1	$17.0K	6
PHARMA DRUGS & MEDI Repaglinide Accord 2	$10.6K	7

Intas Pharmaceuticals Limited exports 93 distinct Repaglinide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PH.DRU.& MED.: VATINID 2MG TABLETS REPAGLINIDE TABLETS 2MG E with 2 shipments worth $50.1K.

How Does Intas Pharmaceuticals Limited Compare to Nearest Repaglinide Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	AUROBINDO PHARMA LIMITED	$1.8M	136	6	$13.0K
3	USV PRIVATE LIMITED	$883.7K	46	4	$19.2K
4	INTAS PHARMACEUTICALS LIMITED ★	$343.0K	173	6	$2.0K
5	MACLEODS PHARMACEUTICALS LTD	$267.7K	17	1	$15.7K
6	GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED	$48.3K	15	2	$3.2K

Intas Pharmaceuticals Limited ranks #4 among 41 Indian Repaglinide exporters. Average shipment value of $2.0K compared to the market average of $168.2K. The closest competitors by value are AUROBINDO PHARMA LIMITED and USV PRIVATE LIMITED.

Which Indian Ports Ship Repaglinide Exports?

Port	Shipments	% Share
HYDERABAD ICD (INSNF6)	110	13.4%
HYDERABAD ICD	95	11.6%
SAHAR AIR	81	9.9%
HYDERABAD AIR	54	6.6%
SAHAR AIR CARGO ACC (INBOM4)	51	6.2%
DELHI AIR	48	5.9%
ICD SANATHNAGAR, HYD	48	5.9%
DELHI AIR CARGO ACC (INDEL4)	46	5.6%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Repaglinide Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Repaglinide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 188 individual customs records matching Intas Pharmaceuticals Limited exporting Repaglinide, covering 93 formulations to 6 countries via 23 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 36+ countries, 112+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Repaglinide

Repaglinide

Intas Pharmaceuticals Limited — Repaglinide Exporter Profile

Intas Pharmaceuticals Limited — Repaglinide Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Repaglinide?

Who Are the Top Buyers of Repaglinide from Intas Pharmaceuticals Limited?

What Is India's Total Repaglinide Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Repaglinide Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Repaglinide Exporters?

What Repaglinide Formulations Does Intas Pharmaceuticals Limited Export?

How Does Intas Pharmaceuticals Limited Compare to Nearest Repaglinide Exporters?

Which Indian Ports Ship Repaglinide Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Repaglinide Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Repaglinide Export Data from Intas Pharmaceuticals Limited

Repaglinide Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source